ReviewCells2021

Bruton's Tyrosine Kinase Inhibitors: A New Generation of Promising Agents for Multiple Sclerosis Therapy.

Antonio García-MerinoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.